OTC Markets EXMKT - Delayed Quote USD
GlobeStar Therapeutics Corporation (GSTC)
0.0001
0.0000
(0.00%)
At close: May 12 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. James C. Katzaroff | President, CEO, Secretary, Principal Executive Officer & Chairman of the Board | 180k | -- | 1957 |
| Ms. Brooke Greenwald | Chief Marketing Officer | -- | -- | -- |
| Mr. David Croom | Executive Vice President | -- | -- | -- |
GlobeStar Therapeutics Corporation
719 Jadewin Avenue
Richland, WA 99352
United States
- Sector:
- Healthcare
- Industry: Biotechnology
Description
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.
Corporate Governance
GlobeStar Therapeutics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
January 14, 2025 at 12:00 AM UTC
15-12G: Notice of termination of registration of a class of securities under Section 12(g)
Related Tickers
BSSP Baseline Productions, Inc.
0.0001
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0018
+125.00%
GRTX Galera Therapeutics, Inc.
0.0230
+2.22%
PXMD PaxMedica, Inc.
0.0001
0.00%
INAB IN8bio, Inc.
0.1600
-1.84%
PTNT Palatin Technologies, Inc.
0.0890
+3.49%
LCTX Lineage Cell Therapeutics, Inc.
0.4700
-1.90%
APLT Applied Therapeutics, Inc.
0.4401
-4.86%
PTN Palatin Technologies, Inc.
0.0941
-44.65%
CTMX CytomX Therapeutics, Inc.
2.5000
+17.37%